Guide
Navigating DSCSA compliance
Everything you need to know about the Drug Supply Chain Security Act (DSCSA) and resources to help you naviagate compliance.
Dispenser resources
All PDFs available in English only.
Announcements and resources from the FDA
Waivers and exemptions beyond the stabilization period
On June 12, 2024, the FDA announced exemptions for small dispensers from certain requirements of section 582 of the FD&C Act until November 27, 2026, while those who do not meet this exemption can request a waiver, exception, or exemption if they have concerns about readiness or patient access.
Stabilization period of DSCSA until November 2024
The FDA has announced it will not enforce DSCSA until November 27, 2024, allowing an additional year for manufacturers, distributors, dispensers, and trading partners to refine their systems and processes while continuing to show progress and prepare for compliance.
DSCSA dispenser checklist
Available in English only.
DSCSA support for manufacturers
By streamlining packaging and logistics guidelines for our manufacturer partners, we ensure sites of care receive their products quickly and safely. We have created additional resources to help our
manufacturer partners prepare for the enhanced unit level tracking requirements effective November 2023.
Announcements
ICYMI: Watch our DSCSA webinar on-demand
Missed our webinar on navigating DSCSA compliance for dispensers? Watch the 30-minute session, led by Gregg Gorniak, VP of Manufacturer Operations & Data Services at Cencora, to learn about the final DSCSA exemption deadline on November 27, 2025. The webinar covers compliance requirements, options for accessing serialized data, and resources to help you avoid disruptions.
DSCSA in the news
Pharma industry shifts toward full activation
In the fourth part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of US supply chain, explores how public-private collaboration, smarter sourcing strategies, and long-term manufacturer support are helping to fortify pharmaceutical supply chains against future crises.
